Search Results - "MESKER, W"

Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations by van Pelt, G. W., Kjær-Frifeldt, S., van Krieken, J. H. J. M., Al Dieri, R., Morreau, H., Tollenaar, R. A. E. M., Sørensen, F. B., Mesker, W. E.

“…The tumor-stroma ratio (TSR) has been reported as a strong, independent prognostic parameter in colon cancer as well as in other epithelial cancer types, and…”
Get full text

The prognostic value of tumour–stroma ratio in primary breast cancer with special attention to triple-negative tumours: a review by Kramer, C. J. H., Vangangelt, K. M. H., van Pelt, G. W., Dekker, T. J. A., Tollenaar, R. A. E. M., Mesker, W. E.

“…Purpose There is a strong need to improve the prognostication of breast cancer patients in order to prevent over- and undertreatment, especially when…”
Get full text

The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial by Huijbers, A., Tollenaar, R.A.E.M., v Pelt, G.W., Zeestraten, E.C.M., Dutton, S., McConkey, C.C., Domingo, E., Smit, V.T.H.B.M., Midgley, R., Warren, B.F., Johnstone, E.C., Kerr, D.J., Mesker, W.E.

“…The intra-tumor stroma percentage in colon cancer (CC) patients has previously been reported by our group as a strong independent prognostic parameter…”
Get full text

Prognostic significance of the tumor-stroma ratio: validation study in node-negative premenopausal breast cancer patients from the EORTC perioperative chemotherapy (POP) trial (10854) by Dekker, T. J. A., van de Velde, C. J. H., van Pelt, G. W., Kroep, J. R., Julien, J-P., Smit, V. T. H. B. M., Tollenaar, R. A. E. M., Mesker, W. E.

“…The tumor-stroma ratio has previously been shown to be prognostic for patients with invasive breast cancer. We present a validation study to assess the…”
Get full text

Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts by Hawinkels, L J A C, Paauwe, M, Verspaget, H W, Wiercinska, E, van der Zon, J M, van der Ploeg, K, Koelink, P J, Lindeman, J H N, Mesker, W, ten Dijke, P, Sier, C F M

“…The interaction between epithelial cancer cells and cancer-associated fibroblasts (CAFs) has a major role in cancer progression and eventually in metastasis…”
Get full text

The BMP pathway either enhances or inhibits the Wnt pathway depending on the SMAD4 and p53 status in CRC by Voorneveld, P W, Kodach, L L, Jacobs, R J, van Noesel, C J M, Peppelenbosch, M P, Korkmaz, K S, Molendijk, I, Dekker, E, Morreau, H, van Pelt, G W, Tollenaar, R A E M, Mesker, W, Hawinkels, L J A C, Paauwe, M, Verspaget, H W, Geraets, D T, Hommes, D W, Offerhaus, G J A, van den Brink, G R, ten Dijke, P, Hardwick, J C H

“…Background: Constitutive Wnt activation is essential for colorectal cancer (CRC) initiation but also underlies the cancer stem cell phenotype, metastasis and…”
Get full text

Prognostic value of tumor–stroma ratio combined with the immune status of tumors in invasive breast carcinoma by Vangangelt, K. M. H., van Pelt, G. W., Engels, C. C., Putter, H., Liefers, G. J., Smit, V. T. H. B. M., Tollenaar, R. A. E. M., Kuppen, P. J. K., Mesker, W. E.

“…Purpose Complex interactions occur between cancer cells and cells in the tumor microenvironment. In this study, the prognostic value of the interplay between…”
Get full text

Outcomes following pancreatic surgery using three different thromboprophylaxis regimens by Hanna‐Sawires, R. G., Groen, J. V., Klok, F. A., Tollenaar, R. A. E. M., Mesker, W. E., Swijnenburg, R. J., Vahrmeijer, A. L., Bonsing, B. A., Mieog, J. S. D.

“…Background Postpancreatectomy haemorrhage (PPH) and venous thromboembolism (VTE) are serious complications following pancreatic surgery. The aim was to assess…”
Get full text

Reliability of core needle biopsy for determining ER and HER2 status in breast cancer by Dekker, T.J.A., Smit, V.T.H.B.M., Hooijer, G.K.J., Van de Vijver, M.J., Mesker, W.E., Tollenaar, R.A.E.M., Nortier, J.W.R., Kroep, J.R.

“…Several studies have assessed the concordance of estrogen receptor (ER) and human epidermal growth factor receptor 2 (HER2) status between core needle biopsy…”
Get full text

The prognostic role of TGF-β signaling pathway in breast cancer patients by de Kruijf, E.M., Dekker, T.J.A., Hawinkels, L.J.A.C., Putter, H., Smit, V.T.H.B.M., Kroep, J.R., Kuppen, P.J.K., van de Velde, C.J.H., ten Dijke, P., Tollenaar, R.A.E.M., Mesker, W.E.

“…The transforming growth factor-β (TGF-β) pathway has dual effects on tumor growth. Seemingly, discordant results have been published on the relation between…”
Get full text

Association Between the Most Frequent Complications After Surgery for Stage I–III Colon Cancer and Short-Term Survival, Long-Term Survival, and Recurrences by Breugom, A. J., van Dongen, D. T., Bastiaannet, E., Dekker, F. W., van der Geest, L. G. M., Liefers, G. J., Marinelli, A. W. K. S., Mesker, W. E., Portielje, J. E. A., Steup, W. H., Tseng, L. N. L., van de Velde, C. J. H., Dekker, J. W. T.

“…Background The purpose of this study was to identify the ten most frequent complications after surgery for stage I–III colon cancer and to assess the…”
Get full text

A high tumour-stroma ratio (TSR) in colon tumours and its metastatic lymph nodes predicts poor cancer-free survival and chemo resistance by Strous, M. T. A., Faes, T. K. E., Gubbels, A. L. H. M., van der Linden, R. L. A., Mesker, W. E., Bosscha, K., Bronkhorst, C. M., Janssen-Heijnen, M. L. G., Vogelaar, F. J., de Bruïne, A. P.

“…Purpose Despite known high-risk features, accurate identification of patients at high risk of cancer recurrence in colon cancer remains a challenge. As tumour…”
Get full text

Detection of serum N-glycans based on changes over time for earlier detection of pancreatic cancer in high-risk individuals by Levink, I., Klatte, D., Hanna-Sawires, R., Ibrahim, I., van der Burgt, Y., Overbeek, K., Koopmann, B., Cahen, D., Fuhler, G., Wuhrer, M., Bonsing, B., Tollenaar, R., Vleggaar, F., Vasen, H., van Leerdam, M., Bruno, M., Mesker, W.

Get full text

Longitudinal changes of serum protein N-Glycan levels for earlier detection of pancreatic cancer in high-risk individuals by Levink, I.J.M., Klatte, D.C.F., Hanna-Sawires, R.G., Vreeker, G.C.M., Ibrahim, I.S., van der Burgt, Y.E.M., Overbeek, K.A., Koopmann, B.D.M., Cahen, D.L., Fuhler, G.M., Wuhrer, M., Bonsing, B.A., Tollenaar, R.A.E.M., Vleggaar, F.P., Vasen, H.F.A., van Leerdam, M.E., Bruno, M.J., Mesker, W.E.

“…Surveillance of individuals at risk of developing pancreatic ductal adenocarcinoma (PDAC) has the potential to improve survival, yet early detection based on…”
Get full text

Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach by Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., van de Vijver, M. J.

“…Assessing hormone receptor status is an essential part of the breast cancer diagnosis, as this biomarker greatly predicts response to hormonal treatment…”
Get full text

Quantitative assessment of lymph vascular space invasion (LVSI) provides important prognostic information in node-negative breast cancer by Dekker, T.J.A., van de Velde, C.J.H., van Bruggen, D., Mesker, W.E., van der Hoeven, J.J.M., Kroep, J.R., Tollenaar, R.A.E.M., Smit, V.T.H.B.M.

“…Some studies investigating the prognostic value of lymph vascular space invasion (LVSI) have shown an association between LVSI and disease-free survival…”
Get full text

Comment on: The prognostic significance of tumour-stroma ratio in oestrogen receptor-positive breast cancer by Mesker, W E, Dekker, T J A, de Kruijf, E M, Engels, C C, van Pelt, G W, Smit, V T H B M, Tollenaar, R A E M

Get full text

Results from the UNITED study: a multicenter study validating the prognostic effect of the tumor–stroma ratio in colon cancer by Polack, M., Smit, M.A., van Pelt, G.W., Roodvoets, A.G.H., Meershoek-Klein Kranenbarg, E., Putter, H., Gelderblom, H., Crobach, A.S.L.P., Terpstra, V., Petrushevska, G., Gašljević, G., Kjær-Frifeldt, S., de Cuba, E.M.V., Bulkmans, N.W.J., Vink, G.R., Al Dieri, R., Tollenaar, R.A.E.M., van Krieken, J.H.J.M., Mesker, W.E., Petrushevska, Gordana, Bogdanovska, Magdalena, Zdravkoski, Panche, Antovic, Svetozar, Dzambaz, Darko, Karagjozov, Panche, de Cuba, Erienne M.V., Beverdam, Frédérique, Jansen, Jan, Vermaas, Maarten, Gašljević, Gorana, Kjær-Frifeldt, Sanne, Lindebjerg, Jan, Strous, Maud, Vogelaar, Jeroen F., Bulkmans, Nicole W.J., van Baarlen, Joop, Mekenkamp, Leonie, Hoekstra, Ronald, Sie, Mark, Cuatrecasas, Miriam, Simonetti, Sara, Rodrigo, María Teresa, Sanz, Iván Archilla, Guerrero Pineda, Jose, Leeuwis-Fedorovich, Natalja E., Talsma, Koen A., Souza da Silva, Ricella M., Lacle, Miangela M., Koopman, Miriam, Dekker, Jan Willem T., van Tilburg, Arjan, Nuciforo, Paolo, Villalobos Alberú, Xenia, Landolfi, Stefania, Zucchiatti, Adriana, Witteveen, Emma, Bordbar, Arad, Hendriks, Mathijs P., Arensman, René, Natu, Shonali, Maka, Noori, Mesker, Wilma E., Tollenaar, Rob A.E.M., Polack, Meaghan, Smit, Marloes A., van Pelt, Gabi W., Putter, Hein, Meershoek-Kleinenbarg, Elma, Roodvoets, Annet G.H., Crobach, Augustinus S.L.P., Gelderblom, Hans, Fontes e Sousa, Mário, Borralho Nunes, Paula, Cruz, João, Raimundo, Ana, Silva, Nelson, Brito, Maria J., Terpstra, Valeska, Zakhartseva, L.M., Al Dieri, Raed, Fléjou, Jean-François, Feakins, Roger, Dequeker, Els, Vink, Geraldine R., van Krieken, J.Han J.M.

“…The TNM (tumor–node–metastasis) Evaluation Committee of Union for International Cancer Control (UICC) and College of American Pathologists (CAP) recommended to…”
Get full text

The value of tumor-stroma ratio as predictor of pathologic response after neoadjuvant chemoradiotherapy in esophageal cancer by van Pelt, G.W., Krol, J.A., Lips, I.M., Peters, F.P., van Klaveren, D., Boonstra, J.J., de Steur, W.O., Tollenaar, R.A.E.M., Farina Sarasqueta, A., Mesker, W.E., Slingerland, M.

“…•Scoring the tumor-stroma ratio is a simple and reproducible method.•Tumor-stroma ratio and response to neoadjuvant chemoradiotherapy are…”
Get full text

Erratum to: Quality assessment of estrogen receptor and progesterone receptor testing in breast cancer using a tissue microarray-based approach by Dekker, T. J. A., ter Borg, S., Hooijer, G. K. J., Meijer, S. L., Wesseling, J., Boers, J. E., Schuuring, E., Bart, J., van Gorp, J., Bult, P., Riemersma, S. A., van Deurzen, C. H. M., Sleddens, H. F. B. M., Mesker, W. E., Kroep, J. R., Smit, V. T. H. B. M., van de Vijver, M. J.

Get full text